Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
46
GBOOF Quote, Financials, Valuation and Earnings
Last price:
$6.70
Seasonality move
:
4.22%
Day range:
$6.54 - $7.00
52-week range:
$6.17 - $11.35
Dividend yield:
10.21%
P/E ratio:
6.15x
P/S ratio:
1.59x
P/B ratio:
1.43x
Volume:
19.3K
Avg. volume:
28.3K
1-year change:
-29.21%
Market cap:
$18.5B
Revenue:
$11.1B
EPS (TTM):
$1.07
Analysts' Opinion
-
Consensus RatingGrupo Financiero Banorte SAB de CV has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Grupo Financiero Banorte SAB de CV has an estimated downside of -- from its current price of $6.58.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $6.58.
Fair Value
-
According to the consensus of 0 analysts, Grupo Financiero Banorte SAB de CV has -- downside to fair value with a price target of -- per share.
GBOOF vs. S&P 500
-
Over the past 5 trading days, Grupo Financiero Banorte SAB de CV has underperformed the S&P 500 by -5.93% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Grupo Financiero Banorte SAB de CV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Grupo Financiero Banorte SAB de CV has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Grupo Financiero Banorte SAB de CV reported revenues of $6.2B.
Earnings Growth
-
Grupo Financiero Banorte SAB de CV has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Grupo Financiero Banorte SAB de CV reported earnings per share of $0.53.
Enterprise value:
20.6B
EV / Invested capital:
1.03x
Price / LTM sales:
1.59x
EV / EBIT:
1.13x
EV / Revenue:
1.73x
PEG ratio (5yr expected):
0.99x
EV / Free cash flow:
7.62x
Price / Operating cash flow:
7.03x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.31%
Net Income Margin (TTM):
25.77%
Return On Equity:
21.64%
Return On Invested Capital:
14.02%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $8.1B | $10.6B | $11.9B | $6B | $6.2B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.75 | $1.01 | $1.07 | $0.53 | $0.53 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.6B | $7B | $12.7B | $18B | $10.9B | |
| Total Assets | $80.2B | $87.9B | $101B | $131B | $123.1B | |
| Current Liabilities | $2.9B | $2.7B | $6B | $4.8B | $4.7B | |
| Total Liabilities | $70.5B | $76.4B | $88.9B | $116.6B | $110.2B | |
| Total Equity | $9.7B | $11.5B | $12.1B | $14.4B | $12.9B | |
| Total Debt | $6.1B | $5.8B | $5.3B | $7.4B | $7.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$495.7M | $4.6B | $3.1B | -$911.1M | -$785.8M | |
| Cash From Investing | -$145.1M | -$528.1M | -$211.9M | -$43.2M | -$60.9M | |
| Cash From Financing | -$1.9B | -$3.2B | -$3.4B | -$250.7M | -$652.1M | |
| Free Cash Flow | $3.3B | $3.8B | $2.7B | -$1.1B | -$875.6M | |
GBOOF
Sector
Market Cap
$18.5B
$698.9M
Price % of 52-Week High
58%
88.68%
Dividend Yield
10.21%
2.18%
Shareholder Yield
15.48%
3.87%
1-Year Price Total Return
-29.21%
7.42%
Beta (5-Year)
0.772
0.734
Dividend yield:
10.21%
Annualized payout:
$0.75
Payout ratio:
70.69%
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.64
200-day SMA
Sell
Level
$8.24
Bollinger Bands (100)
Sell
Level
6.75 - 7.49
Chaikin Money Flow
Buy
Level
3.1M
20-day SMA
Sell
Level
$6.79
Relative Strength Index (RSI14)
Sell
Level
46.30
ADX Line
Buy
Level
12.43
Williams %R
Neutral
Level
-63.8952
50-day SMA
Sell
Level
$6.96
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
3.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8543)
Sell
CA Score
(Annual)
Level (-1.537)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (0.7072)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Grupo Financiero Banorte SAB de CV is a Mexican financial services company. The company offers a wide variety of products and services including banking services, brokerage, wholesale banking, leasing, factoring, insurance, pensions, and retirement savings. It operates locally in Mexico.
Stock Forecast FAQ
In the current month, GBOOF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GBOOF average analyst price target in the past 3 months is --.
-
Where Will Grupo Financiero Banorte SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Grupo Financiero Banorte SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Grupo Financiero Banorte SAB de CV?
Analysts are divided on their view about Grupo Financiero Banorte SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Grupo Financiero Banorte SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Grupo Financiero Banorte SAB de CV's Price Target?
The price target for Grupo Financiero Banorte SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GBOOF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Grupo Financiero Banorte SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GBOOF?
You can purchase shares of Grupo Financiero Banorte SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Grupo Financiero Banorte SAB de CV shares.
-
What Is The Grupo Financiero Banorte SAB de CV Share Price Today?
Grupo Financiero Banorte SAB de CV was last trading at $6.70 per share. This represents the most recent stock quote for Grupo Financiero Banorte SAB de CV. Yesterday, Grupo Financiero Banorte SAB de CV closed at $6.58 per share.
-
How To Buy Grupo Financiero Banorte SAB de CV Stock Online?
In order to purchase Grupo Financiero Banorte SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
